BeOne Medicines AG (BVMF:B1ME34)
66.50
-5.40 (-7.51%)
At close: Nov 5, 2025
BeOne Medicines AG Revenue
BeOne Medicines AG had revenue of 10.05B CNY in the quarter ending September 30, 2025, with 43.11% growth. This brings the company's revenue in the last twelve months to 35.40B, up 52.67% year-over-year. In the year 2024, BeOne Medicines AG had annual revenue of 27.81B with 59.51% growth.
Revenue (ttm)
35.40B CNY
Revenue Growth
+52.67%
P/S Ratio
7.48
Revenue / Employee
3.22M CNY
Employees
11,000
Market Cap
198.27B BRL
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.81B | 10.38B | 59.51% |
| Dec 31, 2023 | 17.43B | 7.67B | 78.53% |
| Dec 31, 2022 | 9.77B | 2.29B | 30.69% |
| Dec 31, 2021 | 7.47B | 5.46B | 270.56% |
| Dec 31, 2020 | 2.02B | -965.08M | -32.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vale S.A. | 213.32B |
| Ambev | 90.47B |
| Banco do Brasil | 74.40B |
| Telefônica Brasil | 58.57B |
| Rede D'Or São Luiz | 54.20B |
| Banco Santander (Brasil) | 49.31B |
| Centrais Elétricas Brasileiras S.A. - Eletrobrás | 42.64B |
| WEG S.A. | 41.38B |